Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Ashtead Group    AHT   GB0000536739


News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Ashtead : What's at stake for Europe Inc in a trade spat with Washington

share with twitter share with LinkedIn share with facebook
share via e-mail
05/14/2019 | 03:10am EDT
U.S. Trade Representative Lighthizer and EU Trade Commissioner Malmstrom take part in a meeting to discuss steel overcapacity in Brussels

LONDON (Reuters) - Europe's listed companies are expected to generate 1.2 trillion euros (£1.0 trillion) in revenue from the United States this year, highlighting what's at stake as global trade tensions grow and earnings and economic growth stall.

Analysts and investors say that based on revenues, European companies are more vulnerable to a dispute than their competitors in the United States.

U.S. President Donald Trump is due to decide by Saturday whether to impose duties on car imports, potentially posing another significant threat to global growth and denting Europe's prized auto sector.

Washington's renewed tensions with Beijing may distract Trump and delay a decision beyond the May 18 deadline, or he may crank up his protectionist push with a global trade war on two fronts.

Last month, he also threatened to impose tariffs on hundreds of European goods, from cheese to ski suits, worth $11 billion.

The impact on Europe's top firms could be profound -- with slowing economic growth and some countries like Italy struggling with bulging budget deficits, the region may not be as resilient to a prolonged dispute as China has so far proven.

In the past six months, the Chinese government has launched stimulus measures from tax cuts to boosting lending to shore up the world's No. 2 economy as the trade spat rumbles on.

"I'm much more concerned about trade for Europe than I am for China," said Christophe Donay, head of asset allocation at Pictet Wealth Management.

According to Europe's top asset manager Amundi Asset Management, U.S sales average about 20% of MSCI Europe companies' aggregate turnover, while European sales average about 14% of turnover for companies in MSCI's U.S. share index,

For an interactive version of the below graphic, click herehttps://tmsnrt.rs/2VGtZSu.


Typically, Europe's carmakers are considered particularly vulnerable to Trump's protectionism.

A 25% tariff could result in a 0.2-0.3 percentage point loss of export revenue and GDP for Germany, according to an analysis by Moody's. The United States accounts for 13% of Germany's car exports, the ratings agency has said.

Measured by revenue, there's a lot at stake for companies like Fiat Chrysler with $45.3 billion in U.S. revenues. But many, like Fiat, have their own U.S. production plants, sheltering them slightly from any outright tariffs.

For an interactive version of the below graphic, click herehttps://tmsnrt.rs/2LCr9KG.

Caroline Simmons, deputy head of the UK investment office of UBS Global Wealth Management, said she would expect the technology, energy and industrial sectors to be worst-hit by any further antagonism.

Average European company exposure to the United States in those sectors ranges from 10 to 20% in terms of sales, compared with 33% for healthcare.

UBS is underweight consumer discretionary in the euro zone, which includes autos, partly because of the trade tariffs.

"The market is nervous about it and last year (the U.S.-China spat) escalated more than people expected and the effect on the market was bigger than people had anticipated," she said.


Of pan-European STOXX 600 index companies, those in healthcare have the highest revenue exposure on average.

An analysis by Refinitiv based on companies' estimates of 2019 revenue shows they draw some 133.3 billion euros in revenue from the world's No. 1 economy and top drug market.

For an interactive version of the below chart, click herehttps://tmsnrt.rs/2WwCixg.

While healthcare has not been implicated in the tit-for-tat between Washington and Brussels so far, some investors worry about the potential fall-out from souring relations between the two economic powerhouses.

"As these sectors are in normal times regarded as defensive, they may doubly disappoint if the U.S. and Europe also engage in a tariff war," said Ibra Wane, equity strategist at Amundi, in a note this week.

The European healthcare index has risen 8% since the late December low, underperforming most other industries and lagging behind an 11% rise in the benchmark STOXX 600.

Pharma and medical equipment companies from BTG to BB Biotech and Fresenius Medical Care are among the most exposed individual companies, with 67-90% of total sales derived from the United States.

Capital goods companies Ashtead and Ferguson are also high up on the list, with more than 80% of their sales made to the United States.

(Reporting by Josephine Mason and Ritvik Carvalho; Graphics by Ritvik Carvalho; Editing by Catherine Evans)

By Josephine Mason and Ritvik Carvalho

Stocks mentioned in the article
ChangeLast1st jan.
ASHTEAD GROUP -0.96% 2275 Delayed Quote.40.32%
BB BIOTECH AG 0.31% 64 Delayed Quote.9.25%
BTG 0.00% 840 Delayed Quote.1.20%
CHEESE FUTURES (CSC) - CMG (ELECTRONIC)/C1 0.00% 1.903 End-of-day quote.38.00%
FERGUSON PLC -1.82% 5940 Delayed Quote.20.59%
FIAT CHRYSLER AUTOMOBILES -0.52% 12.336 End-of-day quote.-2.22%
FRESENIUS MEDICAL CARE AG & CO. KGAA -0.97% 63.02 Delayed Quote.12.36%
STOXX EUROPE 600 0.29% 392.95 Delayed Quote.15.31%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ASHTEAD GROUP
09/11ASHTEAD : profits increase as firm cashes in on growing demand
09/10ASHTEAD GROUP PLC : - Result of AGM
09/10ASHTEAD : quarterly profit rises, bolstered by strong U.S. rental demand
09/10ASHTEAD : 1st Quarter Results
09/06ASHTEAD GROUP PLC : - Transaction in Own Shares
09/05ASHTEAD : 1st Quarter Results
09/05ASHTEAD GROUP PLC : - 1st Quarter Results
09/04ASHTEAD GROUP PLC : - Transaction in Own Shares
09/02ASHTEAD GROUP PLC : - Transaction in Own Shares
08/29ASHTEAD GROUP PLC : - Transaction in Own Shares
More news
Financials (GBP)
Sales 2020 5 254 M
EBIT 2020 1 461 M
Net income 2020 918 M
Debt 2020 4 073 M
Yield 2020 1,92%
P/E ratio 2020 11,6x
P/E ratio 2021 10,4x
EV / Sales2020 2,76x
EV / Sales2021 2,49x
Capitalization 10 418 M
Duration : Period :
Ashtead Group Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASHTEAD GROUP
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 19
Average target price 2 588,87  GBp
Last Close Price 22,75  GBp
Spread / Highest target 13 966%
Spread / Average Target 11 280%
Spread / Lowest Target 9 351%
EPS Revisions
Geoffrey Drabble Chief Executive Officer & Executive Director
Paul Ashton Walker Chairman
Brendan Horgan Chief Operating Officer & Executive Director
Michael Pratt Finance Director, Treasurer & Executive Director
Lucinda Jane Riches Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
ASHTEAD GROUP40.32%13 144
AIR LEASE CORP43.33%4 836